Lv51
1140 积分 2024-11-22 加入
PDE4 inhibition in pediatric psoriasis: analysis of the SPROUT study on apremilast
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of TQC3721, an innovative, dual PDE3 and PDE4 inhibitor, in healthy subjects and patients with chronic obstructive pulmonary disease: Randomised, double-blind, placebo-controlled phase I and IIa clinical trials
1个月前
已完结
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients With COPD in China (PACER-II)
1个月前
已完结
Difamilast Ointment, a Topical PDE4 Inhibitor, for Pediatric Cheilitis Granulomatosa: A Steroid‐Sparing Outcome
1个月前
已完结
Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study
1个月前
已完结
Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis
1个月前
已完结
Pharmacogenetic mechanism of cilostazol‐induced headaches: Splicing‐mediated loss of ABCC5 gene function
1个月前
已完结
Safety and Efficacy of Triple Therapy Containing Encorafenib, Cetuximab, and Binimetinib for BRAF V600E-Mutated Colorectal Cancer: a Systematic Review and Meta-Analysis
2个月前
已完结
[A retrospective study of BRAF inhibitors and EGFR inhibitors combined with immune checkpoint inhibitors in patients with microsatellite stable, BRAF V600E mutated metastatic colorectal cancer]
2个月前
已完结
FDA approves PDE4 inhibitor for IPF
5个月前
已完结
皖公网安备34019202002308
